Daiwa Securities Group
ARRY

Daiwa Securities Group’s Array Biopharma Inc ARRY Stock Holding History

Daiwa Securities Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,388
Closed -$64K – 1224
2019
Q2 		$64K Hold
1,388
– – ﹤0.01% 958
2019
Q1 		$34K Buy
1,388
+299
+27% +$6.22K ﹤0.01% 966
2018
Q4 		$16K Hold
1,089
– – ﹤0.01% 979
2018
Q3 		$17K Hold
1,089
– – ﹤0.01% 1011
2018
Q2 		$18K Hold
1,089
– – ﹤0.01% 1015
2018
Q1 		$18K Buy
+1,089
New +$17.4K ﹤0.01% 995

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Daiwa Securities Group's ARRY Position: Q3 2019 in Review

Daiwa Securities Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,388 shares — an estimated $64K sold.

Daiwa Securities Group first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $64K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Daiwa Securities Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 1,388 Array Biopharma Inc shares in Q3 2019, an estimated $64K.
  • Daiwa Securities Group first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
  • Daiwa Securities Group's Array Biopharma Inc position peaked at $64K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.